Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00804167 |
Describe the clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
Condition |
---|
Hypertension |
Study Type: | Observational |
Study Design: | Cohort, Cross-Sectional |
Official Title: | Profile of Hypertensive Patients Aged of 75 Years and Older Seen in General Practitioner According to Their Renal Damage. |
Estimated Enrollment: | 4500 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | April 2009 |
Ages Eligible for Study: | 75 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
The first 3 consecutive patients seen during the GP's visit with a diagnosis of Hypertension and with renal damage
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca France Clinical Study, Information | 01 41 29 40 00 | stephan.becouarn@astrazeneca.com |
Study Director: | Alain Castaigne, Medical Director | AstraZeneca |
Responsible Party: | AstraZeneca Pharmaceuticals ( Alain Castaigne, Medical Director ) |
Study ID Numbers: | NIS-CFR-DUM-2008/1 |
Study First Received: | December 5, 2008 |
Last Updated: | December 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00804167 History of Changes |
Health Authority: | France: French Data Protection Authority |
Hypertensive patients aged of 75 years and older renal damage Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage |
Vascular Diseases Hypertension |
Vascular Diseases Cardiovascular Diseases Hypertension |